financetom
Business
financetom
/
Business
/
--Axos Financial Halted Pending News Release
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Axos Financial Halted Pending News Release
Jun 4, 2024 12:21 PM

02:58 PM EDT, 06/04/2024 (MT Newswires) --

Price: 48.79, Change: -3.67, Percent Change: -7.00

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google says feedback shows old search result format is bad for hotels
Google says feedback shows old search result format is bad for hotels
Dec 12, 2024
BRUSSELS, Dec 12 (Reuters) - A return to the format of 10 blue links in search results from years ago could reduce user traffic to hotels, Google said on Thursday, as it seeks to balance demands from price comparison websites and hotels in trying to comply with EU tech rules. The Alphabet unit has announced a series of changes in...
Archer Aviation raises $430 million through equity offering, partners with Anduril
Archer Aviation raises $430 million through equity offering, partners with Anduril
Dec 12, 2024
(Reuters) - Air-taxi maker Archer Aviation ( ACHR ) said on Thursday it has raised $430 million in fresh capital, part of which will be used to develop a hybrid aircraft with defense tech company Anduril Industries. Existing investors United Airlines and Stellantis ( STLA ) as well as new backers such as Wellington Management and Abu Dhabi investment holding...
Star Group to Acquire Home Energy Distributor for $68 Million
Star Group to Acquire Home Energy Distributor for $68 Million
Dec 12, 2024
09:02 AM EST, 12/12/2024 (MT Newswires) -- Star Group ( SGU ) said Thursday it entered into an agreement to acquire an unnamed home energy distributor for approximately $68 million. The distributor is situated within Star Group's ( SGU ) current operating footprint, the company said, adding that it expects to close the deal within the next 45 days. ...
Pfizer Says Adding Ibrance Extends Progression-Free Survival in Phase 3 Breast Cancer Study
Pfizer Says Adding Ibrance Extends Progression-Free Survival in Phase 3 Breast Cancer Study
Dec 12, 2024
09:02 AM EST, 12/12/2024 (MT Newswires) -- Pfizer ( PFE ) and Alliance Foundation Trials said Thursday that results from a phase 3 trial of the drug Ibrance showed that adding it to standard-of-care therapies extended median progression-free survival by over 15 months in patients with metastatic breast cancer. The study involved patients with hormone receptor-positive, human epidermal growth factor...
Copyright 2023-2026 - www.financetom.com All Rights Reserved